Skip to main content
. 2022 Jul 30;14(8):1590. doi: 10.3390/pharmaceutics14081590

Figure 3.

Figure 3

Inhibition of GPI biosynthesis pathway in Leishmania by different repurposed and/or potential drug candidates.